Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04861714 · ClinicalTrials.gov registry record · NA
Evaluation of Regeneten Augmentation for Subscapularis Healing After Total Shoulder Arthroplasty (RESTOR)
A NA study of Arthroplasty, Replacement, Shoulder, sponsored by Ohio State University.
- Active
- Registry status
- NA
- Development phase
- 75
- Enrollment target
- 1
- Study location
NCT04861714: Active NA study of Arthroplasty, Replacement, Shoulder, sponsored by Ohio State University.
NCT04861714 is a NA study of Arthroplasty, Replacement, Shoulder that is active but no longer recruiting, run by Ohio State University. The registered enrollment target is 75 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04861714, a NA study of Arthroplasty, Replacement, Shoulder, is active but no longer recruiting, sponsored by Ohio State University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 75 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate whether augmentation of subscapularis repair with the Regeneten implant after anatomic total shoulder arthroplasty (TSA) can improve rates of subscapularis healing and improve clinical outcomes.
Primary Outcome
Pounds (lbs) of force that the subject can produce during the lift off test will be recorded.
Conditions Studied
Interventions
- DEVICE Regeneten
- PROCEDURE Standard repair
Study Locations (1)
Ohio
- The Ohio State University Sports Medicine Center - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2020-07-14 |
| Est. Completion | 2027-04 |
| Phase | NA |
What the registry record for NCT04861714 still lists
NCT04861714 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 75 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Arthroplasty, Replacement, Shoulder appearing as the primary indexed condition, and to 2 interventions - of which Regeneten is the first listed.
NCT04861714 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT04861714 about?
NCT04861714 is a clinical study titled "Evaluation of Regeneten Augmentation for Subscapularis Healing After Total Shoulder Arthroplasty (RESTOR)". The purpose of this study is to evaluate whether augmentation of subscapularis repair with the Regeneten implant after anatomic total shoulder arthroplasty (TSA) can improve rates of subscapularis healing and improve clinical outcomes.
What is the current status of trial NCT04861714?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 75 participants. The study started on 2020-07-14. Estimated completion is 2027-04.
What conditions does trial NCT04861714 study?
This clinical trial studies the following conditions: Arthroplasty, Replacement, Shoulder.
What interventions are being tested in trial NCT04861714?
The interventions under investigation include: Regeneten (DEVICE), Standard repair (PROCEDURE).
Who is sponsoring clinical trial NCT04861714?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04861714 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Arthroplasty, Replacement, Shoulder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04861714's enrollment target sits among peer trials
75 1069th of 2000 higher than 919 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01535430 · 75 participants
Assessment of Eloquent Function in Brain Tumor Patients
- NCT01542879 · 75 participants · Phase 1
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
- NCT02232191 · 75 participants · Phase 2
Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients
- NCT02754544 · 75 participants · NA
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI